Eric D. Tetzlaff

639 total citations
37 papers, 401 citations indexed

About

Eric D. Tetzlaff is a scholar working on Oncology, Pulmonary and Respiratory Medicine and General Health Professions. According to data from OpenAlex, Eric D. Tetzlaff has authored 37 papers receiving a total of 401 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 11 papers in Pulmonary and Respiratory Medicine and 10 papers in General Health Professions. Recurrent topics in Eric D. Tetzlaff's work include Gastric Cancer Management and Outcomes (7 papers), Economic and Financial Impacts of Cancer (6 papers) and Advances in Oncology and Radiotherapy (6 papers). Eric D. Tetzlaff is often cited by papers focused on Gastric Cancer Management and Outcomes (7 papers), Economic and Financial Impacts of Cancer (6 papers) and Advances in Oncology and Radiotherapy (6 papers). Eric D. Tetzlaff collaborates with scholars based in United States, Spain and South Korea. Eric D. Tetzlaff's co-authors include Jaffer A. Ajani, Karen Ruth, Arlene M. Correa, Michael P. Kosty, Jonathan Cheng, Margaret von Mehren, Todd Pickard, Jackie Baker, Caroline Schenkel and Stephanie Williams and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Clinical Cancer Research.

In The Last Decade

Eric D. Tetzlaff

35 papers receiving 391 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Eric D. Tetzlaff United States	12	127	121	100	84	75	37	401
Adena Scheer Canada	14	318 2.5×	91 0.8×	56 0.6×	316 3.8×	84 1.1×	48	680
Hye Jung Chang South Korea	14	275 2.2×	146 1.2×	25 0.3×	77 0.9×	62 0.8×	26	543
Debrah Wirtzfeld Canada	17	255 2.0×	135 1.1×	84 0.8×	225 2.7×	171 2.3×	33	719
Kwonoh Park South Korea	13	112 0.9×	167 1.4×	20 0.2×	82 1.0×	64 0.9×	49	385
Marc Antoni Broggi Spain	7	177 1.4×	41 0.3×	16 0.2×	146 1.7×	33 0.4×	16	424
Fadila Farsi France	13	192 1.5×	175 1.4×	99 1.0×	84 1.0×	114 1.5×	40	526
Jennifer M. Kolb United States	16	166 1.3×	258 2.1×	14 0.1×	365 4.3×	12 0.2×	83	778
Jorge Riera Knorrenschild Germany	12	282 2.2×	331 2.7×	128 1.3×	207 2.5×	157 2.1×	44	700
Philip Smart Australia	11	126 1.0×	73 0.6×	15 0.1×	179 2.1×	17 0.2×	48	329
Resmi A. Charalel United States	13	33 0.3×	88 0.7×	64 0.6×	97 1.2×	32 0.4×	47	448

Countries citing papers authored by Eric D. Tetzlaff

Since Specialization

Citations

This map shows the geographic impact of Eric D. Tetzlaff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric D. Tetzlaff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric D. Tetzlaff more than expected).

Fields of papers citing papers by Eric D. Tetzlaff

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eric D. Tetzlaff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric D. Tetzlaff. The network helps show where Eric D. Tetzlaff may publish in the future.

Co-authorship network of co-authors of Eric D. Tetzlaff

This figure shows the co-authorship network connecting the top 25 collaborators of Eric D. Tetzlaff. A scholar is included among the top collaborators of Eric D. Tetzlaff based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eric D. Tetzlaff. Eric D. Tetzlaff is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Schenkel, Caroline, Laura A. Levit, M. Kelsey Kirkwood, et al.. (2025). State of Professional Well-Being, Satisfaction, and Career Plans Among US Oncologists in 2023. PubMed. 2(2). e2400010–e2400010. 4 indexed citations

Tetzlaff, Eric D., et al.. (2025). The Impact of the COVID-19 Pandemic on Work-Life Integration of Physician Assistants in Oncology. Journal of the Advanced Practitioner in Oncology. 16(7). 1–10. 1 indexed citations

Movva, Sujana, Elizabeth A. Handorf, Edwin Choy, et al.. (2023). SAR-096: Phase II Clinical Trial of Ribociclib in Combination with Everolimus in Advanced Dedifferentiated Liposarcoma (DDL) and Leiomyosarcoma (LMS). Clinical Cancer Research. 30(2). 315–322. 14 indexed citations

Tetzlaff, Eric D., et al.. (2023). Moral Distress, Organizational Climate, and the Risk of Burnout Among Physician Assistants in Oncology. JCO Oncology Practice. 19(5). e639–e649. 5 indexed citations

Schenkel, Caroline, Laura A. Levit, Rebecca Spence, et al.. (2023). The state of workforce retention among US oncologists.. JCO Oncology Practice. 19(11_suppl). 42–42. 1 indexed citations

Ravi, Vinod, Scott M. Schuetze, Sujana Movva, et al.. (2022). OER‐073: A multicenter phase 2 study evaluating the role of pazopanib in angiosarcoma. Cancer. 128(19). 3516–3522. 12 indexed citations

Tetzlaff, Eric D., et al.. (2020). Addressing PA burnout. JAAPA. 33(7). 10–11.

Movva, Sujana, Margaret von Mehren, Elizabeth A. Handorf, et al.. (2020). SAR-096: A phase II trial of ribociclib in combination with everolimus in advanced dedifferentiated liposarcoma (DDL), and leiomyosarcoma (LMS).. Journal of Clinical Oncology. 38(15_suppl). 11544–11544. 9 indexed citations

Mehren, Margaret von, Samuel Litwin, Vinod Ravi, et al.. (2019). Multicenter phase II trial of pazopanib (P) in patients with angiosarcoma (AS).. Journal of Clinical Oncology. 37(15_suppl). 11039–11039. 5 indexed citations

10.

Bruinooge, Suanna S., Todd Pickard, Wendy Vogel, et al.. (2018). Understanding the role of advanced practice providers in oncology in the United States. JAAPA. 31(12). 1–12. 8 indexed citations

11.

Bruinooge, Suanna S., Todd Pickard, Wendy Vogel, et al.. (2018). Understanding the Role of Advanced Practice Providers in Oncology in the United States. Oncology nursing forum. 45(6). 786–800. 3 indexed citations

12.

Bruinooge, Suanna S., Todd Pickard, Wendy Vogel, et al.. (2018). Understanding the Role of Advanced Practice Providers in Oncology in the United States. Journal of Oncology Practice. 14(9). e518–e532. 48 indexed citations

13.

Bruinooge, Suanna S., Todd Pickard, Wendy Vogel, et al.. (2018). Understanding the Role of Advanced Practice Providers in Oncology in the United States. Journal of the Advanced Practitioner in Oncology. 9(6). 11 indexed citations

14.

Tetzlaff, Eric D., Putao Cen, & Jaffer A. Ajani. (2008). Emerging drugs in the treatment of advanced gastric cancer. Expert Opinion on Emerging Drugs. 13(1). 135–144. 12 indexed citations

15.

Tetzlaff, Eric D.. (2007). Factors to consider before referring patients for major cancer surgery. JAAPA. 20(3). 21–28. 1 indexed citations

16.

Tetzlaff, Eric D., et al.. (2007). Physician Assistants in Oncology. Journal of Oncology Practice. 3(5). 283–283. 2 indexed citations

17.

Tetzlaff, Eric D., Arlene M. Correa, Jackie Baker, Joe Ensor, & Jaffer A. Ajani. (2007). The impact on survival of thromboembolic phenomena occurring before and during protocol chemotherapy in patients with advanced gastroesophageal adenocarcinoma. Cancer. 109(10). 1989–1995. 30 indexed citations

18.

Tetzlaff, Eric D., Josephine Faust, & Jaffer A. Ajani. (2006). Longterm survival of a Western patient with metastatic gastric cancer treated with S-1 plus cisplatin. Gastric Cancer. 9(2). 140–143. 4 indexed citations

19.

Tetzlaff, Eric D. & Jaffer A. Ajani. (2005). Oxaliplatin-Based Chemotherapy for the Treatment of a Metastatic Carcinoid Tumor. International Journal of Gastrointestinal Cancer. 36(1). 55–58. 9 indexed citations

20.

Kemeny, Nancy E., Ahmed Shawky Eid, J.A. Stockman, et al.. (2005). Hepatic arterial infusion of floxuridine and dexamethasone plus high-dose Mitomycin C for patients with unresectable hepatic metastases from colorectal carcinoma. Journal of Surgical Oncology. 91(2). 97–101. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact